Eight years ago, he donated a kidney to a stranger, and now runs an advocacy group for kidney donors. The opportunity to save someone else’s life meant a great deal to him, and he sees challenge trials as a chance to do it again. So far, about 30,000 people from 140 countries have signed up online saying they might participate in a challenge trial. “Our goal is not to manage the manufacturing process or trial process ourselves,” he said. “Our goal is to make the preconditions, so that if challenge trials would be useful, they’re available.

Source: New York Times July 01, 2020 19:05 UTC